Delayed recurrences, common in breast cancer, are well explained by the concept of tumour dormancy. Numerous publications describe clinical times to disease recurrence or death, using mathematical approaches to infer mechanisms responsible for delayed recurrences. However, most of the clinical literature discussing tumour dormancy uses data from over a half century ago and much has since changed. This review explores how current breast cancer treatment could change our understanding of the biology of breast cancer tumour dormancy, and summarizes relevant experimental models to date. Current knowledge gaps are highlighted and potential areas of future research are identified. © 2007 BioMed Central Ltd.
CITATION STYLE
Brackstone, M., Townson, J. L., & Chambers, A. F. (2007, May 31). Tumour dormancy in breast cancer: An update. Breast Cancer Research. https://doi.org/10.1186/bcr1677
Mendeley helps you to discover research relevant for your work.